1 Desensitization is an important characteristic of glutamate receptors of the a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) type. 2 Stimulation of N-methyl-D-aspartate (NMDA) or AMPA receptors in cerebellum results in increased production of cyclic GMP. We have investigated AMPA receptor desensitization in vivo by monitoring extracellular cyclic GMP during intracerebellar microdialysis in conscious unrestrained adult rats.
Introduction
Results from in vitro (Bredt & Snyder, 1989; Garthwaite et al., 1989; Garthwaite, 1991) , ex vivo (Wood et al., 1990; Wood, 1991) and in vivo microdialysis (Luo et al., 1994;  Vallebuona & Raiteri, 1994) studies are consistent with the idea that, in the cerebellum, guanosine 3': 5'-cyclic monophosphate (cyclic GMP) is involved in the mediation by nitric oxide (NO) of the actions of glutamate/aspartate at excitatory amino acid ionotropic receptors. In particular, in vivo activation of receptors of the N-methyl-D-aspartate (NMDA) as well as of the cx-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) type was reported to result in NO-dependent increases in the extracellular levels of cyclic GMP in the cerebellum of adult (Luo et al., 1994; Vallebuona & Raiteri, 1994) and aged (Vallebuona & Raiteri, 1995) rats. Responses to agonists at AMPA receptors have been shown to desensitize in several in vitro systems (Mayer & Vyklicky, 1989; Sommer et al., 1990; Trussell et al., 1993) . Desensitization of AMPA receptors can be blocked by drugs such as diazoxide (Yamada & Rothman, 1992) and cyclothiazide (Partin et al., 1993; Patneau et al., 1993; Barnes et al., 1994; Desai et al., 1994; Rammes et al., 1994; Sharp et al., 1994) .
It is believed that NMDA and AMPA/kainate receptors often coexist on the same membrane (Bekkers & Stevens, 1989; Young & Fagg, 1990) . Experiments with nerve terminals isoAuthor for correspondence. lated from rat striatum (Desce et al., 1992) or hippocampus (Raiteri et al., 1992) showed that NMDA and AMPA receptors are colocalized on the same nerve terminal and appear to interact with each other in regulating striatal dopamine or hippocampal noradrenaline release. In particular, it seems that activation of AMPA receptors permits activation of NMDA receptors in the presence of Mg2' ion concentrations that normally prevent NMDA receptor function.
We have investigated here in vivo AMPA receptor desensitization by monitoring extracellular cyclic GMP during intracerebellar microdialysis in freely-moving rats. The study was extended to examine possible interactions between AMPA and NMDA receptors linked to the NO/cyclic GMP system.
Methods

Dialysis procedure
Male Sprague-Dawley rats (250-300 g, CD-COBS, Charles River, Calco, Italy) were anaesthetized with Equitesin, 3 ml kg-', placed on a stereotaxic frame (David Kopf In- struments) and implanted with a microdialysis probe which was transversely positioned into the cerebellum according to the following coordinates: AP = -2.3, H = + 6.0 from the interaural line (Paxinos & Watson atlas, 1986) . A piece of dialysis fibre made of a co-polymer of acrylonitrile sodium methallyl sulphonate (AN69HF Hospal S.p.A., Bologna, Italy; Brifish Journal of Pharmacology (1996) 117, 1133 -1138 In vivo desensitization of AMPA receptors 0.3 mm outer diameter with more than 40,000 mol. wt cut-off) was covered with epoxy glue to confine dialysis to the area of interest (8 mm glue-free zone). The skull was exposed and two holes were drilled on the lateral surface at the level of the cerebellar cortex. One dialysis probe, held straight by a tungsten wire inside, was inserted transversely into the brain so that the glue-free zone was exactly located in the target area. The tungsten wire was withdrawn and stainless steel cannulae (22-gauge diameter, about 15 mm long) were glued to the ends of the fibre. These ends were bent up and fixed vertically to the skull with dental cement and modified Eppendorf tips (see also Vallebuona & Raiteri, 1993) . After a 24 h recovery period, rats were placed into perspex cages and the probes perfused at a flow rate of 5 MI min-' (CMA/100 microinjection pump, Carnergie Medicine, Stockholm, Sweden) with artificial cerebrospinal fluid (artificial CSF) containing (in mM): NaCl 145, KCl 3, CaCl2 1.26, MgCl2 1, buffered at pH 7.4 with 2 mM phosphate buffer. Consecutive samples were collected every 20 min following a washout period of 1 h and assayed for their cyclic GMP content by a commercially available radioimmunoassay kit (Amersham dual range, Amersham Radiochemical Centre, Buckinghamshire, U.K.). At the end of the experiment, rats were killed and the correct position of the probe was verified by histological examination of the fibre tract. The in vitro recovery for cyclic GMP under our experimental conditions was 18 + 1.5% (n = 3).
Statistics and expression of results
The data presented are expressed as percentages of basal values. The cyclic GMP content of the first 2 -3 samples collected was averaged and defined as 100%. Differences between control and drug-treated animals were analysed by two-way ANOVA with repeated measures over time followed by Newman-Keuls multiple comparison test or Student's t test as appropriate. Differences were considered significant at the level of P<0.05.
vented by DNQX (100 gM) when the antagonist was applied 20 min before AMPA. Local administration of the NO synthase inhibitor, L-NOARG (100 Mm) also prevented the AMPA-induced cyclic GMP response. The cyclic GMP extracellular levels fell significantly below basal during NO synthase inhibition.
During the 20 min pretreatment with DNQX (40-60 min fraction in Figure 1 ), the basal level of cyclic GMP decreased significantly. Such a decrease was again observed after 100 min, i.e. when the infusion of AMPA (min 60 to 80) was terminated, but DNQX was still present in the perfusate. This observation prompted us to ascertain if AMPA receptors are activated by endogenous glutamate during ongoing neuronal activity. As shown in Figure 2 , local administration of DNQX (100 gM) decreased by about 60% the basal extracellular levels of cyclic GMP. In contrast, these levels remained unaffected when the NMDA receptor antagonist MK-801 was applied locally via the microdialysis probe.
To investigate effects of cyclothiazide on the AMPA-evoked cyclic GMP response, an experimental paradigm frequently used in release studies from brain slices was employed ( Figure   X (Vallebuona & Raiteri, 1993; Luo et al., 1994) . Local application of the excitatory amino acid agonist, AMPA (10 to 100 Mm) via the microdialysis probe evoked a concentration-dependent increase in extracellular cyclic GMP levels ( Figure 1 ). As the response elicited by 100 gM AMPA did not differ significantly from that produced by 50 gM AMPA, the latter dose appears to produce near-maximal response. The effect of AMPA (100 gM) was completely pre- 3). Two subsequent 20 min AMPA (100 gM) stimuli (SI = 40 to 60 min; S2= 140 to 160 min) were applied. A group of rats was locally infused with cyclothiazide (100 gM) starting 20 min before S2 up to the end of the experiment. S2/SI ratios were then calculated to evaluate quantitatively the effect of cyclothiazide. As illustrated in Figure 3 and summarized in Table  1 , the cyclic GMP response to the second application of AMPA was strongly reduced with respect to the first (S2/ SI = 0.295 + 0.06); however, in the presence of cyclothiazide, the second response to AMPA (S2) was strongly potentiated (S2/S1 = 0.7 + 0.11) as compared to the S2 observed in the absence of cyclothiazide. If normal ongoing synaptic activity in freely-moving animals includes AMPA receptor activation (Figure 2) , cyclothiazide might on its own affect the basal extracellular levels of cyclic GMP. Indeed, local infusion of cyclothiazide through the dialysis probe elicited concentration-dependent cyclic GMP responses (Figure 4) . The cyclic GMP elevations produced by 300 and 100 yM cyclothiazide did not differ significantly from each other during the first 40 min of exposure (60 to 100 min). However, the response to 100 uM cyclothiazide fell to basal between 100 and 140 min, in spite of the continuous presence of the drug, while the cyclic GMP response to 300 gM cyclothiazide remained constant during drug application. As expected, the effect of cyclothiazide (300 gM) by DNQX (100 gM) . Surprisingly, however, the effect of 300 gM cyclothiazide was also prevented by MK-801 (30 Mm; Figure 4 ).
This result with MK-801 suggests that the cyclic GMP response to AMPA could include a NMDA component. However, the results depicted in Figure 5 clearly Figure 5 in Vallebuona & Raiteri, 1994 versus I work; see also Luo et al., 1994) probably due to the dialysis medium of Mg2" ions, known NMDA-operated channel (Mayer et al., 1984) .
The cyclic GMP response elicited by exog depends on activation of NO synthase and proc as it was abolished completely by locally infuse Moreover, the NO synthase inhibitor produ decrease of basal extracellular levels of cyclic G that basal levels of cyclic GMP largely origii synthase activity (Figure 1 ; see also Vallebot 1994).
Ongoing glutamatergic synaptic transmission involves activation of AMPA but not NMDA receptors
As expected, the selective non-NMDA ionotropic receptor antagonist, DNQX, abolished the AMPA-evoked cyclic GMP reponse (Figure 1 ). Interestingly, a decrease in the basal level of cyclic GMP during DNQX pretreatment and following termination of AMPA infusion was observed (Figure 1 ). This suggested that AMPA receptors could be activated by endogenous excitatory amino acids, a view clearly supported by subsequent experiments (Figure 2) showing that DNQX, infused in the absence of AMPA, significantly lowered the basal outflow of cyclic GMP. Local infusion of MK-801, a selective blocker of the NMDA receptor channel, did not lower basal cyclic GMP levels indicating that the NMDA receptors found in previous microdialysis experiments to be linked to cyclic GMP production (Luo et al., 1994; Vallebuona & Raiteri, 1994) are not tonically activated in vivo. Since infusion of L-NOARG lowered the basal cyclic GMP efflux (Vallebuona & Raiteri, 1994 ; see also Agonist responses at AMPA-preferring glutamate receptors have been shown to desensitize in several in vitro systems (Mayer & Vyklicky, 1989; Sommer et al., 1990; Trussell et al., 1993) . Cyclothiazide can inhibit AMPA receptor desensitizaitatively to the tion (Partin et al., 1993; Patneau et al., 1993; Yamada & Tang, rclic GMP ele-1993; Barnes et al., 1994; Desai et al., 1994; Sharp et al., 1994) .
To investigate in vivo AMPA receptor desensitization, AMPA was infused locally during two subsequent 20 min periods (Si and S2). The S2 cyclic GMP response was strongly reduced with respect to SI under control conditions, but much less so when cyclothiazide was present during S2 (Figure 3 and lar cyclic Table 1 ). The low S2/SI ratio seen in controls may have been due to a number of factors, including 'metabolic' unbalances due to the infusion, during SI, of a supramaximal (100 gM) vn that AMPA concentration of AMPA. However, the result with cyclothia- Raiteri, 1994) , zide suggests that, in controls, the S2 response was weak due .d cyclic GMP largely to AMPA receptor desensitization. The use of the twoor antagonists.
stimuli paradigm does not imply, however, that pre-stimula-AMPA in this tion (SI) is required to permit desensitization during a subiMPA, infused sequent AMPA treatment. In fact, Figure 6 shows that a single ,tryptamine (5-AMPA treatment evoked a cyclic GMP response that could be Whitton et al., strongly potentiated by cyclothiazide. acellular cyclic It was reported that intrahippocampal infusion of 1 gM ous concentra-AMPA elicited increase of extracellular 5-HT, while 100 gM luced maximal AMPA was inhibitory (Whitton et al., 1994) . Since diazoxide, ,es at 100 gM. a blocker of AMPA receptor desensitization (Yamada & produced a rise Rothman, 1992) , changed the inhibitory effect of 100 Mm m AMPA (cf.
AMPA into a stimulation of 5-HT efflux, Whitton et al. (1994) Figure 1 in this proposed that AMPA receptors desensitized at high, but not the presence in low AMPA concentrations. The results of Luo et al. (1994) (Staubli et al., 1994; Zivkovic et al., 1995) .
Endogenous desensitization of AMPA receptors
The observation that AMPA receptors are activated by endogenous excitatory amino acids during spontaneous neural activity together with the finding that, in our system, AMPA receptors desensitize when exposed to low concentrations of exogenous AMPA (see Figure 6 ) raised the question as to whether endogenous glutamate released under basal conditions is sufficient to induce receptor desensitization.
Infusion of cyclothiazide increased the extracellular levels of cyclic GMP (Figure 4 ), suggesting that, under 'normal' conditions, the release of endogenous glutamate due to ongoing synaptic activity keeps the receptors in a partly desensitized state. As previously hypothesized (Moudy et al., 1994) , such an endogenous desensitization may represent a homeostatic mechanism of autoprotection against glutamatergic injury.
Several electrophysiological studies in brain slices and in isolated cells (see Introduction) have shown that AMPA receptor desensitization is a phenomenon with a time course of a few milliseconds and that recovery from desensitization requires 10 to a few hundred milliseconds. On the other hand, a number of in vitro neurochemical works (May & Robison, 1993; Barnes et al., 1994; Desai et al., 1994) showed that potentiation of AMPA-mediated effects by cyclothiazide can be observed during prolonged periods (tens of minutes), possibly as an overall result of repeated desensitization-resensitization episodes occurring if cyclothiazide remains present. It seems particularly relevant that the phenomenon can be observed and characterized in vivo (Whitton et al., 1994 and present work) also in view of the fact that drugs able to prevent AMPA receptor desensitization have been reported to possess cognition enhancing properties in various behavioural tasks (Staubli et al., 1994; Zivkovic et al., 1995) .
AMPA-NMDA receptor interaction and role of AMPA receptor desensitization
As expected, the cyclic GMP response elicited by cyclothiazide was abolished by the selective AMPA/kainate receptor antagonist, DNQX. Surprisingly, however, this response was also blocked by MK-801, a selective antagonist at the NMDAoperated channel, suggesting that cyclothiazide not only enhances the function of an ongoing AMPA receptor-mediated transmission by preventing its desensitization, but also 'triggers' activation of NMDA receptors that are apparently not under tonic activation. Furthermore, as shown in Figure 4 , AMPA and NMDA receptors do not seem to operate in parallel since the cyclothiazide-evoked cyclic GMP response, at least during the first 60 min, could be totally abolished either by DNQX or by MK-801. Instead, the two receptors appear to work in series, the activation of one depending on that of the other. Interestingly, the cyclic GMP response elicited by AMPA/kainate agonists in cultured striatal neurones, insensitive per se to MK-80 1, became sensitive to the antagonist in the presence of concanavalin A, a lectin known to prevent desensitization of non-NMDA receptors (Marin et al., 1993) .
Based on electrophysiological studies, Bekkers & Stevens (1989) proposed that many excitatory synapses possess both NMDA and non-NMDA ionotropic receptors that are colocalized postsynaptically. Accordingly, both receptor types have been found in autoradiographic studies to display parallel distribution in various CNS areas (see Young & Fagg, 1990) .
NMDA and AMPA/kainate receptors coexist on the same striatal dopaminergic (Desce et al., 1992) or hippocampal noradrenergic (Raiteri et al., 1992) axon terminal. Most importantly, activation of these presynaptic AMPA receptors appears to exert a permissive role on the activation of the coexisting NMDA receptors in the presence of otherwise inhibiting Mg2" concentrations (Desce et al., 1992; Raiteri et al., 1992) . Altogether these results suggest one possible explanation for the sensitivity to both DNQX and MK-801 of the cyclic GMP response evoked by cyclothiazide: administration of cyclothiazide could prevent endogenous desensitization of AMPA receptors up to a point that their activation reaches the threshold for activation of adjacent NMDA receptors in the presence of physiological concentrations of Mg2+. Assuming this, complete abrogation of the cyclic GMP response following blockade of either AMPA or NMDA receptors would be justified.
However, this explanation appears not to be sufficient. In fact, if cyclothiazide only increased the level of AMPA receptor activation by preventing endogenous desensitization, administration of exogenous AMPA at high concentrations should permit NMDA receptor activation. However, this is not the case as the cyclic GMP responses to 30 or 100 gM AMPA were blocked by DNQX but insensitive to MK-801 ( Figure 5 ).
The presence of cyclothiazide therefore appears critical. As shown in Figure 6 , infusion of 10 gM AMPA plus 30 gM cyclothiazide (a concentration ineffective per se on the cyclic GMP production) elicited a cyclic GMP response which was sensitive to MK-801. One could therefore hypothesize that cyclothiazide, besides preventing AMPA receptor desensitization, can induce in these receptors changes that favour interaction with adjacent NMDA receptors leading to their activation. The physiological significance of the cyclic GMP released in the extracellular space and the potential physiological relevance of increased cyclic GMP when AMPA receptor desensitization is blocked remain speculative. It has been recently reported that addition of cyclic GMP or its membranepermeable analogues as well as of NO donors to patchclamped cerebellar Purkinje cells was able to mimic long-term depression (Daniel et al., 1993) , a synaptic plasticity phenomenon known to involve AMPA receptors (Ito, 1989) .
